We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$796M
AUM Growth
+$146M
Cap. Flow
+$82M
Cap. Flow %
10.3%
Top 10 Hldgs %
37.64%
Holding
72
New
23
Increased
22
Reduced
9
Closed
15

Top Buys

1
ZBH icon
Zimmer Biomet
ZBH
+$32.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$20.4M
3
INCY icon
Incyte
INCY
+$19.5M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$18.9M
5
AGN
Allergan Inc
AGN
+$18.8M

Top Sells

1
AMGN icon
Amgen
AMGN
+$38.7M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$28.8M
3
STJ
St Jude Medical
STJ
+$25.8M
4
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$23.3M
5
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$23.3M

Sector Composition

1 Healthcare 86.89%
2 Consumer Staples 1.21%
3 Technology 0.56%
4 Communication Services 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$69.7B
$275K 0.03%
1,000
-79,400
-99% -$22.8M
PRTA icon
52
Prothena Corp
PRTA
$441M
$241K 0.03%
+9,100
New +$228K
DYAX
53
DELISTED
DYAX CORPORATION
DYAX
$188K 0.02%
+25,000
New +$190K
VIRX
54
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$166K 0.02%
+167
New +$173K
MRK icon
55
Merck
MRK
$305B
$120K 0.02%
2,515
+524
+26% +$24K
AGIO icon
56
Agios Pharmaceuticals
AGIO
$2.37B
– –
-53,100
Closed -$1.49M
AMGN icon
57
Amgen
AMGN
$193B
– –
-345,700
Closed -$38.7M
BKD icon
58
Brookdale Senior Living
BKD
$3.42B
– –
-757,800
Closed -$19.9M
NUWE icon
59
Nuwellis
NUWE
$288K
– –
0
– -$5.45M
PACB icon
60
Pacific Biosciences
PACB
$475M
– –
-1,574,379
Closed -$8.71M
PGEN icon
61
Precigen
PGEN
$1.83B
– –
-213,033
Closed -$4.82M
PRGO icon
62
Perrigo
PRGO
$1.4B
– –
-1,700
Closed -$210K
SNDA icon
63
Sonida Senior Living
SNDA
$1.85B
– –
-39,820
Closed -$12.6M
VRTX icon
64
Vertex Pharmaceuticals
VRTX
$121B
– –
-108,262
Closed -$8.21M
VSTM icon
65
Verastem
VSTM
$504M
– –
-2,583
Closed -$386K
ZTS icon
66
Zoetis
ZTS
$31.2B
– –
-465,900
Closed -$14.5M
ARIA
67
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-1,264,009
Closed -$23.3M
CTRX
68
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-508,100
Closed -$23.3M
CBST
69
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-452,600
Closed -$28.8M
ARTC
70
DELISTED
ARTHROCARE CORP
ARTC
– –
-342,759
Closed -$12.2M
RPRX
71
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-10,500
Closed -$281K
1 2
3

Similar funds

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
HCMG
Howard Capital Management Group Los Angeles, California $1.51B AUM 21.57% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return